Prelude Therapeutics Incorporated (PRLD) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 84.59M | 105.69M | 58.33M | 76.88M | 102.4M | 135.9M | 156.39M | 182.71M | 205.37M | 235.59M | 234.92M | 260.21M |
| Cash & Short-Term Investments | 81.55M | 103.21M | 54.96M | 73.22M | 99.07M | 133.61M | 153.63M | 179.84M | 201.92M | 232.94M | 230.51M | 254.99M |
| Cash Only | 21.76M | 35.26M | 47.53M | 25.75M | 40.27M | 12.47M | 11.13M | 27.83M | 24.71M | 25.29M | 15.9M | 26.45M |
| Short-Term Investments | 59.8M | 67.96M | 7.42M | 47.46M | 58.8M | 121.14M | 142.49M | 152.02M | 177.22M | 207.64M | 214.61M | 228.54M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 3.04M | 2.48M | 3.37M | 0 | 3.33M | 2.28M | 2.76M | 2.87M | 0 | 2.65M | 4.41M | -1 |
| Total Non-Current Assets | 35.05M | 35.62M | 36.42M | 38.04M | 38.86M | 39.62M | 40.83M | 41.58M | 41.74M | 42.08M | 23.59M | 20.4M |
| Property, Plant & Equipment | 31.5M | 32.28M | 33.08M | 33.89M | 34.7M | 35.47M | 36.38M | 37.13M | 37.4M | 37.74M | 7.08M | 7M |
| Fixed Asset Turnover | 0.14x | 0.17x | 0.19x | - | - | 0.11x | 0.08x | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 3.23M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3.55M | 3.35M | 110K | 4.15M | 4.15M | 4.15M | 4.45M | 4.45M | 4.34M | 4.34M | 16.51M | 13.4M |
| Total Assets | 119.64M | 141.31M | 94.75M | 114.92M | 141.26M | 175.51M | 197.22M | 224.29M | 247.11M | 277.67M | 258.51M | 280.61M |
| Asset Turnover | 0.04x | 0.05x | 0.06x | - | - | 0.02x | 0.01x | - | - | - | - | - |
| Asset Growth % | -15.3% | -19.49% | -51.95% | -48.76% | -42.83% | -36.79% | -23.71% | -20.07% | 24.6% | 25.93% | 6.68% | 8.32% |
| Total Current Liabilities | 41.72M | 52.99M | 18.19M | 20.91M | 19.79M | 25.64M | 22.22M | 23.34M | 17.64M | 21.83M | 16.89M | 15.19M |
| Accounts Payable | 2.07M | 3.98M | 2.53M | 4.96M | 5.83M | 7.73M | 5.92M | 6.17M | 5.31M | 4.58M | 5.17M | 5.58M |
| Days Payables Outstanding | 696.52 | - | - | - | - | - | - | - | - | 1.35K | - | - |
| Short-Term Debt | 2.76M | 2.74M | 2.73M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 30.95M | 33.73M | 0 | 0 | 0 | 0 | 0 | 3M | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 5.94M | 12.53M | 6.45M | 861K | 4.55M | 9.79M | 8.39M | 6.09M | 800K | 6.61M | 7.8M | 809K |
| Current Ratio | 2.03x | 1.99x | 3.21x | 3.68x | 5.18x | 5.30x | 7.04x | 7.83x | 11.64x | 10.79x | 13.91x | 17.13x |
| Quick Ratio | 2.03x | 1.99x | 3.21x | 3.68x | 5.18x | 5.30x | 7.04x | 7.83x | 11.64x | 10.79x | 13.91x | 17.13x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 17.74M | 19.68M | 18.03M | 18.17M | 18.3M | 18.41M | 18.57M | 18.68M | 18.73M | 18.75M | 3.36M | 3.36M |
| Long-Term Debt | 14.96M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 15.04M | 15.13M | 15.21M | 15.27M | 15.32M | 15.41M | 15.46M | 15.45M | 15.41M | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2.78M | 4.64M | 2.9M | 2.97M | 3.03M | 3.09M | 3.15M | 3.21M | 3.28M | 3.34M | 3.36M | 3.36M |
| Total Liabilities | 59.46M | 72.68M | 36.22M | 39.08M | 38.08M | 44.06M | 40.79M | 42.02M | 36.37M | 40.58M | 20.25M | 18.55M |
| Total Debt | 17.72M | 17.79M | 17.85M | 17.92M | 17.92M | 18.02M | 18.14M | 18.2M | 17.64M | 16.89M | 475K | 938K |
| Net Debt | -4.04M | -17.47M | -29.68M | -7.83M | -22.35M | 5.55M | 7M | -9.62M | -7.07M | -8.4M | -15.42M | -25.51M |
| Debt / Equity | 0.29x | 0.26x | 0.31x | 0.24x | 0.17x | 0.14x | 0.12x | 0.10x | 0.08x | 0.07x | 0.00x | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 60.18M | 68.64M | 58.53M | 75.84M | 103.18M | 131.46M | 156.43M | 182.28M | 210.73M | 237.09M | 238.26M | 262.06M |
| Equity Growth % | -41.67% | -47.79% | -62.58% | -58.39% | -51.04% | -44.55% | -34.34% | -30.44% | 20.22% | 21.31% | 9.59% | 8.81% |
| Book Value per Share | 0.73 | 1.09 | 0.77 | 1.00 | 1.36 | 1.73 | 2.06 | 2.41 | 2.78 | 3.41 | 3.52 | 4.66 |
| Total Shareholders' Equity | 60.18M | 68.64M | 58.53M | 75.84M | 103.18M | 131.46M | 156.43M | 182.28M | 210.73M | 237.09M | 238.26M | 262.06M |
| Common Stock | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K |
| Retained Earnings | -693.45M | -683.06M | -666.6M | -646.88M | -615.65M | -583.56M | -554.83M | -522.56M | -487.82M | -456.39M | -423.31M | -392.71M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -41K | 8K | 2K | -1K | 12K | 35K | 167K | -290K | -235K | 223K | -605K | -711K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |